EOFlow Officially Launches iOS Version of the EOPatch App ‘Narsha’
EOFlow Announces Record Revenue for First Quarter 2022; Revenue of 949 Million KRW which is 137% of Last Year’s Annual Revenue
EOFlow Has its First Clinical Study on EOPatch Published in Diabetes & Metabolism Journal
EOFlow to Supply KRW48.8bn Worth of EOPatch to Gulf Drug of UAE
[Fierce Pharma] SanPlena sets out to show wearable patches are the key to faster weight loss
EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH
Menarini has won three tenders for 'GlucoMen Day PUMP' in Italy
EOFlow Receives Approval of Investigational Device Exemption (IDE) Application for its Two-Part Wearable Artificial Pancreas “EOPatch X” for Pivotal Study on People with Type 1 Diabetes in Korea
EOFlow to Supply KRW45.3bn Worth of 'EOPatch' to Indonesian Company
EOFlow Initiates Eco-Friendly Disposal Campaign for EOPatch in Korea Embracing and Integrating Environmental, Social, and Governance (ESG)
EOFlow to Raise 100 Billion Korean Won and Offer Stock Split Capital Raised Will Be Used For Global Market Expansion
EOFlow and Sinocare Establish a Joint Venture Company
EOFlow Begins Clinical Study of its Wearable Insulin Pump “EOPatch” on People With Type 2 diabetes in Korea
EOFlow Completes its First Shipment to Europe